Axon Enterprise financials
$419.58−1.22%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Fiscal year | FY25 Dec 31 | FY24 Dec 31 | FY23 Dec 31 | FY22 Dec 31 | FY21 Dec 31 |
|---|---|---|---|---|---|
| Revenue | $2.78B | $2.08B | $1.56B | $1.19B | $863.4M |
| Gross profit | $1.66B | $1.24B | $955.5M | $726.1M | $540.9M |
| Gross margin | 59.7% | 59.6% | 61.2% | 61.2% | 62.7% |
| Operating income | -$62.1M | $58.5M | $156.8M | $93.0M | -$168.1M |
| Net income | $124.7M | $377.0M | $175.8M | $146.9M | -$60.0M |
| Net margin | 4.5% | 18.1% | 11.3% | 12.4% | −7.0% |
| Diluted EPS | $1.51 | $4.80 | $2.33 | $2.03 | $-0.91 |
| EBITDA | $21.1M | $107.0M | $176.2M | $116.1M | -$149.4M |
| Operating cash flow | $211.3M | $408.3M | $189.3M | $235.4M | $124.5M |
| Free cash flow | $75.1M | $329.5M | $129.6M | $179.6M | $74.6M |
| Diluted shares | 82.4M | 78.6M | 75.5M | 72.5M | 66.2M |
Balance sheet
| Period end | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|
| Cash & equivalents | $1.20B | $454.8M | $598.5M | $353.7M | $356.3M |
| Short-term investments | $532.6M | $531.5M | $722.0M | $621.0M | $86.7M |
| Total debt | $1.81B | $680.3M | $677.1M | $674.0M | $5.4M |
| Total assets | $7.00B | $4.47B | $3.41B | $2.85B | $1.69B |
| Total liabilities | $3.76B | $2.15B | $1.79B | $1.58B | $640.4M |
| Shareholders' equity | $3.24B | $2.33B | $1.62B | $1.27B | $1.05B |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology